Study design and participants
The Ethics Committee of The First Affiliated Hospital of Anhui Medical University approved this research (approval number: PJ2022-01-10). The trial was registered in the Chinese Clinical Trial Registry (ChiCTR2100053388, 20/11/2021) before enrollment of patients and complied with CONSORT (Consolidated Standards of Reporting Trials). All the enrolled individuals provided written consent.
This study is a prospective, randomized controlled clinical trial performed at The First Affiliated Hospital of Anhui Medical University. Elderly patients who planned to undergo gastroscopy under intravenous anesthesia were recruited from February 15, 2022, to September 6, 2022. The inclusion criteria of this study were as follows: males or females of age > 65 years, ASA physical status I – III, BMI 18.5-30 kg/m2, undergoing gastroscopy under intravenous anesthesia; voluntarily participating in this trial and signing informed consent forms (ICFs). The exclusion criteria of this study were as follows: patients with severe cardiovascular and pulmonary diseases; patients who are allergic to anesthetic drugs; patients with nasal diseases such as rhinitis, nasal polyps and epistaxis; patients with acute pharyngitis and tonsillitis; patients with a history of myocardial infarction and unstable angina within the past six months; patients with severe obstructive sleep apnea syndrome; patients requiring a lot of water injection during endoscopy; patients requiring duration of operation for more than 1 hour; patients refusing to participate in this study.
Randomized controlled grouping
Individuals were randomly sorted into the disposable anesthetic nasal mask group or the nasal cannula group based on the computer-generated allocation list. The operator responsible for randomization was blinded to the study design, patient recruitment, and data collection. As the anesthetic nasal masks and nasal cannulas used in this study were easy to distinguish in appearance, anesthesiologists, endoscopists, patients, and data recorders knew the specific grouping. The statistician responsible for data statistics and evaluation of experimental results did not know the specific grouping.
Anesthesia Management
All individuals fasted for at least 8 h before the surgery. According to the requirements of gastroscopy, all individuals were to take 10 ml of oral dyclonine hydrochloride mucilage (Yangtze River Pharmaceutical Group Co., Ltd.) and 30 ml of pronase solution (Beijing Tide Pharmaceutical Co., Ltd.). After entering the room, the individual was administered with a venous channel and set in a left lateral position for standardized monitoring, including peripheral oxygen saturation (SpO2), blood pressure, heart rate and electrocardiogram. To eliminate the impact of varied sedation schemes on the study results, a unified sedation scheme was used for patients who participated in this study. Patients were asked to take at least eight deep breaths with 100% oxygen for 60 seconds, then sufentanil (0.25 μg) was given intravenously, and 2 minutes later, propofol (1-2.0 mg/kg) was given for anesthesia induction. After the patient’s eyelash reflex disappeared, the gastroscope was implanted. The depth of sedation was estimated according to the MOAA/S scores (modified observer's assessment of alertness/sedation) by 0-5 points [31]. The criteria: 5 points: quick response to calling names at a normal volume; 4 points: lethargy, response to calling names at a normal volume; 3 points: response to shouting the names; 2 points: response to mild stimulation or shaking; 1 point: response to the pain caused by squeezing the trapezius muscle; 0 points: no response to the pain caused by squeezing the trapezius muscle. During the operation, propofol was supplemented at 10-30 mg/time as needed to maintain the MOAA/S score at 2 or 3 points. If hypotension (MAP < 70 mmHg) occurred during the operation, fluid replacement and intravenous injection of ephedrine 5 mg were given to correct it; if bradycardia (HR < 50 beats/min) occurred, intravenous injection of atropine 0.5 mg was given.
Airway management
All individuals in the anesthetic nasal mask group received oxygen administration by disposable anesthetic nasal masks. The components of the anesthetic nasal mask include a mask body, a fixed headband, a connector, an end-tidal carbon dioxide detection connector, an extension tube, and two nasal prongs. With this design, the nasal masks allow monitoring of end-tidal carbon dioxide during surgery and provide oxygen delivery. Presently, there are three models for adult patients. According to the mask body size, nasal masks were divided into small sizes (model: AS-C-T), medium sizes (model: AM-C-T) and large sizes (model: AL-C-T). An anesthetic nasal mask with appropriate size should be able to seal the nasal cavity very well. After observing the size of the individual’s nasal cavity, the anesthesiologist selected an appropriate model and fixed it with a headband (Fig. 1A). The connectors of anesthetic nasal masks were connected to the breathing circuit of the anesthesia machine, and the initial oxygen flow rate was 5 L/min.
All patients received oxygen administration with standard double-chamber nasal cannulas in the nasal cannula (Fig. 1B), with an initial oxygen flow rate of 5 L/min.
If SpO2 was ≤ 92% during the operation, an intervention was performed according to the following procedures in sequence: firstly, increase the oxygen flow rate to 10 L/min. Secondly, lift the patient’s lower jaw. Thirdly, remove the gastroscope and perform face mask ventilation in the nasal cannula group; in the anesthetic nasal mask group, perform nasal mask ventilation, and if hypoxemia did not improve, then face mask ventilation was performed. Fourthly, endotracheal intubation for mechanical ventilation was performed. Details are shown in Fig. 2, Hypoxemia Treatment Process.
Outcome measures
The primary outcome measure was the incidence of hypoxemia and severe hypoxemia. In the current research, hypoxemia (desaturation) was described as SpO2 ≤ 92% and duration < 60 s. Severe hypoxemia was defined as intraoperative SpO2 ≤ 75% at any time or duration of hypoxemia ≥ 60 s.
The secondary outcome measures included the following:
1. Duration of hypoxemia (seconds) and lowest intraoperative SpO2.
2. Proportion of patients requiring emergency airway management, defined as hypoxemia that cannot be corrected by increasing oxygen flow and needs to be corrected by jaw lifting, nasal mask ventilation, face mask ventilation, or even endotracheal intubation.
3. Proportion of patients discontinuing gastroscopy refers to the proportion of patients who need to stop the operation urgently, remove the gastroscope body, and perform face mask-assisted ventilation or endotracheal intubation.
4. Relevant time indexes (minutes), including the duration of operation and recovery time from anesthesia. The duration of operation was described as the duration from inserting the endoscope into the oral cavity to removing it after the completion of the operation. The recovery time from anesthesia was defined as the time when the MOAA/S score was 5 points, and the corresponding sedation depth was a quick response to calling names at normal volume [31].
5. Total dose of propofol.
6. Occurrence of adverse events, including cough, hiccups, laryngospasm, epistaxis, dry nose, sore throat, nausea and vomiting etc.
7. Satisfaction: At the end of the operation, the endoscopist and the anesthesiologist were asked to evaluate their satisfaction, respectively. In contrast, patients were asked to evaluate their satisfaction before leaving the consulting room. The full score was 100 points, and a score ≥ 90 points were defined as complete satisfaction [32].
Sample size
The sample size was determined by the software Pass 11.0 (NCSS, LLC, Kaysville, Utah, USA). Reports suggest that the occurrence of hypoxemia is as high as 40% in individuals undergoing gastroscopy under intravenous anesthesia [29]. Assuming that anesthetic nasal masks can decrease the occurrence of hypoxemia from 40% to 20%, the minimum sample size calculated was 109 in each group (α = 0.05, power = 0.9). If the dropout rate was 10%, the minimum sample size required was 242 (121 in each group). In this study, 300 patients were included, which was greater than the minimum sample size.
Statistical analysis
Statistical analyses were conducted using SPSS 23.0. The quantitative data of normal distribution was depicted by mean ± standard deviation (SD), and the difference of the groups were compared by Student's t test. The quantitative data of skewed distribution were depicted by Median (P25, P75), and the groups were compared by the Mann-Whitney U test. The qualitative data were depicted by frequency. The groups were compared by Chi-square test or Fisher's exact tests. The ranked data groups were compared by the Mann-Whitney U test. P < 0.05 was taken as a statistically significant value.